Arun Kumar Shukla

Arun Kumar Shukla is an Indian structural biologist and the Joy-Gill Chair professor at the department of biological sciences and bioengineering at the Indian Institute of Technology, Kanpur.[1] Known for his studies on G protein-coupled receptor, Shukla is a Wellcome Trust-DBT Intermediate Fellow and a recipient of the SwarnaJayanti Fellowship of the Department of Science and Technology.[2] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2017/18. He received the 2021 Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Science.[3]

Arun Kumar Shukla
Born
Kushinagar, Uttar Pradesh, India
NationalityIndian
Alma mater
Known forStudies on G protein-coupled receptor
Awards
Scientific career
Fields
Institutions
Doctoral advisor

Biography
IIT Kanpur

Dr. Arun Kumar Shukla was born on 01 November 1981[4] in Kushinagar in the Indian state of Uttar Pradesh,[5] earned his master's degree in biotechnology from Jawaharlal Nehru University after which he did his doctoral studies under the guidance of Hartmut Michel (Nobel Laureate, 1988) of Max Planck Institute of Biophysics.[1] His post-doctoral work was with Robert J. Lefkowitz (Nobel Laureate, 2012) of Duke University and Brian Kobilka (Nobel Laureate, 2012) of Stanford University and he started his career at Duke University as an assistant professor at their department of medicine. Returning to India, he joined the Indian Institute of Technology, Kanpur (IITK) at the Department of Biological Sciences and Bioengineering (BSBE)[6] where he holds the position of a professor[7] and heads the Laboratory of GPCR Biology.[8]

Shukla is known to have carried out extensive research on G protein-coupled receptor and his research is reported to have led to easier regulation of these receptors for better drug efficacy.[9] He led a team of IITK scientists who developed nanomachines which could be designed to selectively target signalling events inside living cells.[10] The technique developed by them is in use with several drugs that are available in the market such as Telmisartan, Olmesartan, Fexofenadine, Propanolol, and Metoprolol.[5] He has published a number of articles and has contributed chapters to books published by others;[11][note 1] Google Scholar, an online repository of scientific articles has listed 75 of them.[12]

Awards and honours

Shukla received the 2021 Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Science.[3] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2017/18.[13] He has also received the B. M. Birla Science Prize (2017),[14] NASI-Young Scientist Platinum Jubilee Award of the National Academy of Sciences, India (2016),[15] CDRI Award (2018),[16] Shakuntala Amir Chand Prize of the Indian Council for Medical Research (2018)[17][18] and the EMBO Young Investigator Award (2017).[19] He was elected as a fellow of the Indian National Science Academy in 2022.[20]

Selected bibliography

See also

Notes
  1. Please see Selected bibliography section

References
  1. "Arun K. Shukla IITK". www.iitk.ac.in. 30 December 2018. Retrieved 30 December 2018.
  2. "List of Awardees - SwarnaJayanti Fellowships Scheme – 2017-18" (PDF). Department of Science and Technology. 30 December 2018. Retrieved 30 December 2018.
  3. "Shanti Swarup Bhatnagar Prize (SSB) for Science and Technology 2021" (PDF). sbprize.gov.in. Council of Scientific and Industrial Research. Retrieved 26 September 2021.
  4. "Arun Kumar Shukla Biography". Online Hindi world. 27 November 2021.
  5. "Better pill". www.telegraphindia.com. 30 December 2018. Retrieved 30 December 2018.
  6. "BSBE People". www.iitk.ac.in. 30 December 2018. Retrieved 30 December 2018.
  7. "Arun Shukla on Samviti". samviti.com. 30 December 2018. Retrieved 30 December 2018.
  8. "Principal Investigator - Laboratory of GPCR Biology". sites.google.com. 30 December 2018. Retrieved 30 December 2018.
  9. Prasad, R. (1 January 2017). "Drug discovery for GPCR signalling made easy by IIT Kanpur". The Hindu. Retrieved 30 December 2018.
  10. Jayan, T. V. (8 January 2018). "IIT-Kanpur scientist-led team designs nano-machines that can correct anomalies inside living cells". @businessline. Retrieved 30 December 2018.
  11. "Research Publications - Laboratory of GPCR Biology". sites.google.com. 31 December 2018. Retrieved 31 December 2018.
  12. "Arun K. Shukla - Google Scholar Citations". scholar.google.co.in. 31 December 2018. Retrieved 31 December 2018.
  13. "Awardees of National Bioscience Awards for Career Development" (PDF). Department of Biotechnology. 2016. Archived from the original (PDF) on 4 March 2018. Retrieved 20 November 2017.
  14. "BM Birla Science Prize presented". www.thehansindia.com. 31 December 2018. Retrieved 31 December 2018.
  15. "The National Academy of Sciences, India - Activities". www.nasi.org.in. 31 December 2018. Archived from the original on 9 January 2019. Retrieved 31 December 2018.
  16. "List of previous CDRI Awardees" (PDF). Central Drug Research Institute. 31 December 2018. Archived from the original (PDF) on 31 December 2018. Retrieved 31 December 2018.
  17. "Awards - Indian Council of Medical Research". ICMR. 31 December 2018. Archived from the original on 31 December 2018. Retrieved 31 December 2018.
  18. Vishwas (31 December 2018). "News Archive". www.iitk.ac.in. Retrieved 31 December 2018.
  19. "IITK faculty Dr. Arun Shukla, Department of Biosciences & bioengineering has been selected as the EMBO Young Investigator". Pinterest. 30 December 2018. Retrieved 30 December 2018.
  20. "INSA :: Indian Fellows Elected". www.insaindia.res.in. Retrieved 22 October 2022.

Further reading
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.